Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.33 USD
+0.01 (3.89%)
Updated Mar 18, 2024 04:00 PM ET
Pre-Market: $0.35 +0.02 (4.95%) 9:06 AM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 39% (98 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | -1.55 | -2.04 | 59.00 |
Year Ago Quarter Estimate | -3.50 | -0.59 | 50.37 |
Next Quarter Estimate | -0.14 | -2.00 | 60.00 |
Next Year Estimate | -4.26 | 6.92 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 59.00 | 11.90 | 14.24 |
Next Year | 49.16 | 16.00 | 5.68 |
Last 5 Years | NA | 7.10 | 9.00 |
Next 5 Years | NA | 23.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 0.05 | 1.85 |
Price/Cash Flow (MRFY) | NA | 7.89 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -46.32% |
Return on Equity (TTM) | -76.36% | -44.92% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.